Clinical Trial Update: Ketones, SGLT2, HFrEF [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 (early) clinical trial sponsored by The University of Texas Health Science Center at San Antonio is evaluating ketones and SGLT2 inhibitors in people …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction
• Type 2 Diabetes Mellitus

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type2diabetes, Heart Failure With Reduced Ejection Fraction | EARLY_Phase 1 | Status: RECRUITING